1.
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases
2.
3.
Financial care for the vulnerable: Rise and decline of Holland orphan chambers
Pharmaceutical compounding of orphan active ingredients in Belgium : how community and hospital pharmacists can address the needs of patients with rare diseases
Governance of conditional reimbursement practices in the Netherlands
Off-label use of orphan medicinal products: a Belgian qualitative study
4.
5.
Benevolent institutions. 1910.
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects
6.
7.
Bébée; Or, Two Little Wooden Shoes
Systematic review of available evidence on 11 high-priced inpatient orphan drugs
Taxonomic assignment of the ISU for the 334 PCR products (Table S3)